Integer Holdings Co. (NYSE:ITGR) Shares Acquired by GAMMA Investing LLC

GAMMA Investing LLC lifted its stake in Integer Holdings Co. (NYSE:ITGR - Free Report) by 8,697.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 78,123 shares of the medical equipment provider's stock after buying an additional 77,235 shares during the period. GAMMA Investing LLC owned approximately 0.23% of Integer worth $92,190,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the stock. AdvisorNet Financial Inc purchased a new position in shares of Integer in the 1st quarter valued at $28,000. Wealth Enhancement Advisory Services LLC purchased a new position in Integer during the 4th quarter worth $208,000. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Integer during the 4th quarter worth $7,889,000. Brucke Financial Inc. purchased a new position in Integer during the 4th quarter worth $564,000. Finally, Azzad Asset Management Inc. ADV grew its position in Integer by 4.9% during the 4th quarter. Azzad Asset Management Inc. ADV now owns 12,138 shares of the medical equipment provider's stock worth $1,609,000 after purchasing an additional 566 shares during the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

Integer Price Performance

ITGR stock traded up $0.66 during trading on Thursday, reaching $120.83. 296,251 shares of the company were exchanged, compared to its average volume of 374,886. The company has a market cap of $4.22 billion, a P/E ratio of 35.96, a PEG ratio of 1.72 and a beta of 1.03. Integer Holdings Co. has a 52-week low of $104.93 and a 52-week high of $146.36. The stock's 50 day moving average price is $118.69 and its 200 day moving average price is $128.29. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95.

Integer (NYSE:ITGR - Get Free Report) last announced its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. The company had revenue of $437.39 million during the quarter, compared to analysts' expectations of $428.51 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. The firm's quarterly revenue was up 7.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.14 earnings per share. As a group, analysts predict that Integer Holdings Co. will post 6.01 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. KeyCorp lowered their price objective on shares of Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. Truist Financial set a $150.00 target price on shares of Integer and gave the stock a "buy" rating in a research note on Friday, April 25th. Wall Street Zen raised shares of Integer from a "sell" rating to a "hold" rating in a report on Monday, May 19th. Oppenheimer downgraded shares of Integer from an "outperform" rating to a "market perform" rating in a report on Friday, February 21st. Finally, Benchmark lowered their target price on shares of Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a report on Friday, April 25th. Two equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $145.00.

Insiders Place Their Bets

In other news, CEO Joseph W. Dziedzic sold 338,975 shares of the business's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $123.17, for a total value of $41,751,550.75. Following the completion of the transaction, the chief executive officer now owns 47,000 shares of the company's stock, valued at $5,788,990. The trade was a 87.82% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 2.16% of the stock is currently owned by company insiders.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.